Illinois hormone‑therapy bill draws clash over minors' access
[March 31, 2026]
By Sean Reed | The Center Square
(The Center Square) – Legislation in the Illinois Capitol could allow
for more lax rules regarding some hormone medications. Republicans say
the bill was quietly snuck through with vague language that would allow
pharmacists to prescribe a 12-month supply of hormone therapy medication
to minors.
HB 5492, introduced by Rep. Katie Stuart, D-Collinsville, passed an
Illinois House committee earlier this month. If passed into law, the
bill would require all health insurance policies in the state to cover a
full 12-month supply of prescription hormone therapy treatment that is
dispensed in whole at a pharmacy.
Excluding controlled substances, pharmacists would be allowed to
dispense a full year’s supply of hormone therapy treatments at a
patient's request, so long as they have a prescription lasting 12
months.
Presenting the bill to the House Insurance Committee, Stuart said the
intention is to reduce frequent trips to the pharmacy for women
prescribed the treatment, which is typically given to women going
through menopause and younger women with particularly painful periods.
“All this will do is to make sure that health insurance plans allow for
the purchase of up to a 12-month supply at a time. Currently right now,
your health insurance may force you to go once a month,” Stuart said.
“There's really no change in cost to anybody.”
A concern raised by Rep. Adam Niemerg, R-Dieterich, is that the language
of the bill would allow for minors to access hormone replacement and
puberty blocker medications.
“I think it's very important to everybody in this room and everybody in
this committee to know what you're doing here. You're pushing gender
hormone treatment and puberty blockers on young children and that's
wrong,” Niemerg said.
Stuart spoke over Niemerg.
“I’m making sure that women going through menopause can get the
medication that helps them,” Stuart said.
[to top of second column]
|
Photo: Alan Wooten / The Center Square
The bill states that a drug must be approved by the U.S. FDA, but
does not contain language regarding the prescribed purpose of such
drugs. While puberty blocking medications would fall into the
medications the bill could allow, their use is considered off-label
when used in the gender confirmation process.
In a release from the House Republican Organization on Monday,
Stuart was accused of purposefully obscuring the nature of the bill.
“Rep. Katie Stuart knew exactly how radical this proposal was, which
is why she tried not to mention that her bill would allow children
to obtain puberty blockers so they could change their gender,” said
the House Republican Organization.
Before the committee voted to pass the bill, Stuart reiterated the
intended purpose of the bill.
“This will be very important for women at the upper age spectrum
dealing with menopause. I think it's important to note that there
are young girls that suffer from debilitating periods that keep them
out of school for days at a time. We are also going to be able to
help those young girls to make sure that they can get themselves to
school,” said Stuart.
The bill passed by a vote of 10-9, with the stipulation it would
return to the committee for additional hearings as it is amended.
Stuart did not say if any amendments would address aforementioned
concerns.
All contents © copyright 2026 Associated Press. All rights reserved |
